2024

Estimation of improvements in mortality in Spectrum among adults with HIV receiving antiretroviral therapy in high-income countries. Trickey A, Glaubius R, Pantazis N, Zangerle R, Wittkop L, Vehreschild J, Grabar S, Cavassini M, Teira R, d'Arminio Monforte A, Casabona J, Van Sighem A, Jarrin I, Ingle SM, Sterne JAC, Imai-Eaton JW, Johnson LF. JAIDS. Jan 2024.

Longitudinal trends in causes of death among adults with HIV in Europe and North America on antiretroviral therapy from 1996 to 2020: a collaboration of cohort studies. Trickey A, McGinnis KA, Gill MJ, Abgrall S, Berenguer J, Wyen C, Hessamfar M, Reiss P, Kusejko K, Silverberg MJ, Imaz A, Teira R, D'Arminio Monforte A, Zangerle R, Guest J, Papastamopoulos V, Crane HM, Sterling TR, Grabar S, Ingle SM, Sterne JAC. Lancet HIV. Jan 2024.

2023

Life expectancy after 2015 of adults with HIV on long-term antiretroviral therapy in Europe and North America: a collaborative analysis of cohort studies. Trickey A, Sabin CA, Burkholder G, Crane H, d'Arminio Monforte A, Egger M, Gill MJ, Grabar S, Guest JL, Jarrin I, Lampe FC, Obel N, Reyes JM, Stephan C, Sterling TR, Teira R, Touloumi G, Wasmuth JC, Wit F, Wittkop L, Zangerle R, Silverberg MJ, Justice A, Sterne JAC, on behalf of the ART-CC and UK-CHIC. Lancet HIV, 10(5); May 2023

Early antiretroviral therapy not associated with higher cryptococcal meningitis mortality in people with HIV in high-income countries: an international collaborative cohort study. Ingle SM, Miro JM, May MT, Cain LE, Schwimmer C, Zangerle R, Sambatakou H, Cazanave C, Reiss P, Brandes V, Bucher HC, Sabin CA, Vidal F, Obel N, Mocroft A, Wittkop L, d'Arminio Monforte A, Torti C, Mussini C, Furrer H, Konopnicki D, Teira, R, Saag MS, Crane HM, Moore RD, Jacobson JM, Matthews WC, Geng E, Eron JJ, Althoff KN, Kroch A, Lang R, Gill MJ, Sterne JAC, on behalf of ART-CC, COHERE in EuroCoord, CNICS, and NA-ACCORD. Clin Infect Dis. Mar 2023.

Impact of Hepatitis C cure on risk of mortality and morbidity in people with HIV after ART initiation. Chalouni M, Trickey A, Ingle SM, Sepuvelda MA, Gonzalez J, Rauch A, Crane HM, Gill MJ, Rebeiro PF, Rockstroh JK, Franco RA, Touloumi G, Neau D, Laguno M, Rappold M, Smit C, Sterne JAC, Wittkop L, on behalf of ART-CC. AIDS, 37(10); Aug 2023.

Contribution of alcohol use in HIV/hepatitis C virus co-infection to all-cause and cause-specific mortality: a collaboration of cohort studies. Trickey A, Ingle SM, Boyd A, Gill MJ, Grabar S, Jarrin I, Obel N, Touloumi G, Zangerle R, Rauch A, Rentsch CT, Satre DD, Silverberg MJ, Bonnet F, Guest J, Burkholder G, Crane H, Teira R, Berenguer J, Wyen C, Abgrall S, Hessamfar M, Reiss P, d'Arminio Monforte A, McGinnis KA, Sterne JAC, Wittkop L, on behalf of ART-CC. JVH, 30(9); Sep 2023.

HIV-1 drug resistance in people on dolutegravir-based ART: A collaborative cohort analysis. Loosli T, Hossmann S, Ingle SM, Okhai H, Kusejko K, Mouton J, Bellecave P, Van Sighem A, Stecher M, d'Arminio Monforte A, Gill MJ, Sabin CA, Maartens G, Gunthard HF, Sterne JAC, Lessells R, Egger M, Kouyos R on behalf of ART-CC and IeDEA-SA. Lancet HIV. Oct 2023

Integrase strand-transfer inhibitor use and cardiovascular events in adults with HIV: An emulation of target trials in the HIV-CAUSAL and ART-CC Collaborations. Rein SM, Lodi S, Logan R, Touloumi G, Antoniadou A, Wittkop L, Bonnet F, Van Sighem A, Van der Valk M, Reiss P, Klein MB, Young J, Jarrin I, d'Arminio Monforte A, Tavelli A, Meyer L, Tran L, Gill MJ, Lang R, Surial B, Haas AD, Justice AC, Rentsch CT, Phillips A, Sabin CA, Miro JM, Trickey A, Ingle SM, Sterne JAC, Hernan MA, on behalf of the ART-CC and HIV-CAUSAL collaborations. Lancet HIV. Nov 2023.

All-cause hospitalization among people living with HIV according to gender, mode of HIV acquisition, ethnicity and geographic origin in Europe and North America: Findings from the ART-CC cohort collaboration. Rein SM, Lampe FC, Ingle SM, Sterne JAC, Trickey A, Gill MJ, Papastamopoulos V, Wittkop L, Van der Valk M, Kitchen M, Guest JL, Satre DD, Wandeler G, Galindo P, Castilho J, Crane HM, Smith CJ. Lancet Public Health. Lancet HIV. Oct 2023.

2022

Associations of modern initial antiretroviral drug regimens with all-cause mortality in adults with HIV in Europe and North America: a cohort study. Trickey A, Zhang L, Gill MJ, Bonnet F, Burkholder G, Castagna A, Cavassini M, Cichon P, Crane H, Domingo P, Grabar S, Guest JL, Obel N, Psichogiou M, Rava M, Reiss P, Rentsch CT, Riera M, Schuettfort G, Silverberg MJ, Sterne JAC. Lancet HIV. June 2022.

2021

Achieving consistency in measures of HIV-1 viral suppression across countries: derivation of an adjustment based on international antiretroviral treatment cohort data. Johnson LF, Kariminia A, Trickey A, Yiannoutsos CT, Ekouevi DK, Minga AK, Pascom ARP, Han WM, Zhang L, Althoff KN, Rebeiro PF, Murenzi G, Ross J, Hsiao NY, Marsh K. JIAS. 21 Sep 2021

2020

Cause‐specific mortality after diagnosis of cancer among HIV‐positive patients: A collaborative analysis of cohort studies. Trickey A, May MT, Gill MJ, Grabar S, Vehreschild J, Wit FWNM, Bonnet F, Cavassini M, Abgrall S, Berenguer J, Wyen C, Reiss P, Grabmeier-Pfistershammer K, Guest JL, Shepherd L, Teira R, d'Arminio Monforte A, del Amo J, Justice A, Costagliola D, Sterne JACS; The Antiretroviral Therapy Cohort Collaboration (ART-CC). International Journal of Cancer 31 Jan 2020

2019

Parameter estimates for trends and patterns of excess mortality among persons on antiretroviral therapy in high-income European settings. Trickey A, van Sighem A, Stover J, Abgrall S, Grabar S, Bonnet F, Berenguer J, Wyen C, Casabona J, d'Arminio Monforte A, Cavassini M, del Amo J, Zangerle R, Gill MJ, Obel N, Sterne JAC, May MT. AIDS 15 Dec 2019

Improved discrimination of mortality with Veterans Aging Cohort Study (VACS) Index 2.0 in HIV-positive individuals. Tate JP, Sterne JAC, Justice AC; Veterans Aging Cohort Study (VACS) and The Antiretroviral Therapy Cohort Collaboration (ART-CC). AIDS 14 Jan 2019

2018

2017

Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies. Trickey A, May MT, Vehreschild J-J, Obel N, Gill MJ, Crane HM, Boesecke C, Patterson S, Grabar S, Cazanave C, Cavassini M, Shepherd L, d'Arminio Monforte A, van Sighem A, Saag MS, Lampe FC, Hernando V, Montero M, Zangerle R, Justice AC, Sterling TR, Ingle S, & Sterne J. The Lancet HIV, epub before print; 10 May 2017

CD4:CD8 Ratio and CD8 Count as Prognostic Markers for Mortality in Human Immunodeficiency Virus–Infected Patients on Antiretroviral Therapy: The Antiretroviral Therapy Cohort Collaboration (ART-CC). Trickey A, May MT, Schommers P, Tate J, Ingle S, Guest JL, Gill MJ, Zangerle R, Saag M, Reiss P, d'Arminio Monforte A, Johnson M, Lima VD, Sterling TR, Cavassini M, Wittkop L, Costagliola C, Sterne JAC, on behalf of the Antiretroviral Therapy Cohort Collaboration (ART-CC). Clinical Infectious Diseases 65 (6); 15 Sep 2017

2016

Using observational data to emulate a randomized trial of dynamic treatment-switching strategies: an application to antiretroviral therapy. Cain LE, Saag MS, Petersen M, May MT, Ingle SM, Logan R, Robins JM, Abgrall S, Shepherd BE, Deeks SG, Gill MJ, Touloumi G, Vourli G, Dabis F, Vandenhende MA, Reiss P, van Sighem A, Samji H, Hogg RS, Rybniker J, Sabin CA, Jose S, Del Amo J, Moreno S, Rodríguez B, Cozzi-Lepri A, Boswell SL, Stephan C, Pérez-Hoyos S, Jarrin I, Guest JL, Monforte AD, Antinori A, Moore R, Campbell CN, Casabona J, Meyer L, Seng R, Phillips AN, Bucher HC, Egger M, Mugavero MJ, Haubrich R, Geng EH, Olson A, Eron JJ, Napravnik S, Kitahata MM, Van Rompaey SE, Teira R, Justice AC, Tate JP, Costagliola D, Sterne JA, Hernán MA; Antiretroviral Therapy Cohort Collaboration, the Centers for AIDS Research Network of Integrated Clinical Systems, and the HIV-CAUSAL Collaboration. IJE 44 (6); 31 Dec 2015

Mortality of treated HIV-1 positive individuals according to viral subtype in Europe and Canada: collaborative cohort analysis. Antiretroviral Therapy Cohort Collaboration (ART-CC), Canadian Observational Cohort Collaboration (CANOC), The UK Collaborative HIV Cohort Study (UK CHIC), the Collaboration of Observational HIV Epidemiological Research in Europe (COHERE). AIDS 30(3):503-13; 28 Jan 2016

Mortality According to CD4 Count at Start of Combination Antiretroviral Therapy Among HIV-infected Patients Followed for up to 15 Years After Start of Treatment: Collaborative Cohort Study. May MT, Vehreschild JJ, Trickey A, Obel N, Reiss P, Bonnet F, Mary-Krause M, Samji H, Cavassini M, Gill MJ, Shepherd LC, Crane HM, d'Arminio Monforte A, Burkholder GA, Johnson MM, Sobrino-Vegas P, Domingo P, Zangerle R, Justice AC, Sterling TR, Miro JM, Sterne JA. Clin Infect Dis. 62(12):1571-7; 15 Jun 2016

Cause-Specific Mortality in HIV-Positive Patients Who Survived Ten Years after Starting Antiretroviral Therapy. Trickey A, May MT, Vehreschild J, Obel N, Gill MJ, Crane H, Boesecke C, Samji H, Grabar S, Cazanave C, Cavassini M, Shepherd L, d'Arminio Monforte A, Smit C, Saag M, Lampe F, Hernando V, Montero M, Zangerle R, Justice AC, Sterling T, Miro J, Ingle S, Sterne JA. PLoS One. 11(8):e0160460; 15 Aug 2016

Additional papers supported by ART-CC funded staff

Immunologic response in treatment-naïve HIV-2-infected patients: the IeDEA West Africa cohort. Balestre E, Ekouevi DK, Tchounga B, Eholie SP, Messou E, Sawadogo A, Thiébaut R, May MT, Sterne JA, Dabis F; International Epidemiological Database to Evaluate AIDS (IeDEA) West Africa Collaboration. J Int AIDS Soc. 19(1):20044; 8 Feb 2016